España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Edge
Benzinga Research
Benzinga Pro
Log In
Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Cannabis
Cannabis Conference
Earnings
Interviews
Deals
Regulations
Psychedelics
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Seres Therapeutics
MCRB
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$0.9155
-0.00540
-0.59%
At close: -
$0.9580
0.04
4.64%
After Hours: Dec 20, 6:36 PM EDT
Get Report
Comment
Seres Therapeutics (MCRB) Forecast
News
Earnings
Seres Therapeutics (MCRB) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Seres Therapeutics (NASDAQ:MCRB) Stock
Seres Therapeutics Stock (NASDAQ: MCRB)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, December 09, 2024
Seres Therapeutics shares are trading higher ...
Benzinga Newsdesk
Seres Therapeutics' SER-155 Receives FDA Brea...
Benzinga Newsdesk
Thursday, November 14, 2024
Canaccord Genuity Maintains Buy on Seres Ther...
Benzinga Newsdesk
Wednesday, November 13, 2024
Chardan Capital Maintains Buy on Seres Therap...
Benzinga Newsdesk
Seres Therapeutics Q3 2024 GAAP EPS $(0.33) M...
Benzinga Newsdesk
Earnings Scheduled For November 13, 2024
Benzinga Insights
Tuesday, November 12, 2024
What's Next: Seres Therapeutics's Earnings Preview
Benzinga Insights
Thursday, October 24, 2024
This Verizon Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Avi Kapoor
JP Morgan Downgrades Seres Therapeutics to Un...
Benzinga Newsdesk
Thursday, October 10, 2024
Watching Seres Therapeutics; Traders Circulat...
Benzinga Newsdesk
Friday, September 27, 2024
Seres Therapeutics Stockholders Publish Open ...
Benzinga Newsdesk
Seres Therapeutics shares are trading higher ...
Benzinga Newsdesk
Thursday, September 26, 2024
12 Health Care Stocks Moving In Thursday's After-Market Session
Benzinga Insights
Seres Therapeutics Stockholders Approve Sale ...
Benzinga Newsdesk
Friday, September 13, 2024
Canaccord Genuity Maintains Buy on Seres Ther...
Benzinga Newsdesk
Friday, September 06, 2024
Watching Seres Therapeutics; Traders Circulat...
Benzinga Newsdesk
Seres Therapeutics Shares Halted To The Upsid...
Benzinga Newsdesk
Wednesday, August 14, 2024
Canaccord Genuity Maintains Buy on Seres Ther...
Benzinga Newsdesk
Chardan Capital Maintains Buy on Seres Therap...
Benzinga Newsdesk
Tuesday, August 13, 2024
Seres Therapeutics Q2 2024 GAAP EPS $(0.22) B...
Benzinga Newsdesk
Tuesday, August 06, 2024
Seres Therapeutics shares are trading lower a...
Benzinga Newsdesk
Seres Therapeutics Has Signed An Agreement Wi...
Benzinga Newsdesk
Monday, June 10, 2024
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Friday, June 07, 2024
Why GameStop Shares Are Trading Lower By Over 22%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Avi Kapoor
Oppenheimer Downgrades Seres Therapeutics to ...
Benzinga Newsdesk
12 Health Care Stocks Moving In Friday's Intraday Session
Benzinga Insights
Canaccord Genuity Maintains Buy on Seres Ther...
Benzinga Newsdesk
Thursday, June 06, 2024
Seres Therapeutics shares are lower higher af...
Benzinga Newsdesk
Seres Therapeutics shares are trading higher ...
Benzinga Newsdesk
Seres Therapeutics Entered Into A Non-binding...
Benzinga Newsdesk
Thursday, May 09, 2024
Oppenheimer Maintains Outperform on Seres The...
Benzinga Newsdesk
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Wednesday, May 08, 2024
Why Upstart Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Avi Kapoor
Seres Therapeutics shares are trading lower a...
Benzinga Newsdesk
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga Insights
Nasdaq Down Over 50 Points; Uber Posts Q1 Loss
Avi Kapoor
Seres Therapeutics' Q1 Cash And Cash Equivale...
Benzinga Newsdesk
Seres Therapeutics Q1 2024 GAAP EPS $(0.27) B...
Benzinga Newsdesk
Tuesday, April 09, 2024
Seres Therapeutics Concludes Enrollment In Co...
Benzinga Newsdesk
Thursday, March 28, 2024
Seres Therapeutics Announced That On March 25...
Benzinga Newsdesk
Wednesday, March 06, 2024
Oppenheimer Maintains Outperform on Seres The...
Benzinga Newsdesk
Emerson Electric To Rally More Than 19%? Here Are 10 Top Analyst Forecasts For Wednesday
Avi Kapoor
Chardan Capital Maintains Buy on Seres Therap...
Benzinga Newsdesk
Tuesday, March 05, 2024
Seres' $128M In Cash Balance, Planned Savings...
Benzinga Newsdesk
Seres Therapeutics FY GAAP EPS $(0.89) Beats ...
Benzinga Newsdesk
Earnings Scheduled For March 5, 2024
Benzinga Insights
Monday, March 04, 2024
Seres Therapeutics's Earnings: A Preview
Benzinga Insights
Monday, February 26, 2024
Seres Therapeutics Announced That Marella Tho...
Benzinga Newsdesk
Wednesday, January 17, 2024
Seres Therapeutics Reports Inducement Grants ...
Benzinga Newsdesk
Tuesday, January 16, 2024
Oppenheimer Maintains Outperform on Seres The...
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch